Toxicity and preliminary results from a trial of hyperfractionated radiation with or without simultaneous 5-fluorouracil-cisplatin in advanced head and neck squamous cell carcinomas
- 1 January 1992
- journal article
- research article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 2 (1) , 38-40
- https://doi.org/10.1016/s1053-4296(05)80051-7
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Randomized clinical trial of mitomycin c as an adjunct to radiotherapy in head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study.Journal of Clinical Oncology, 1989
- Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.Journal of Clinical Oncology, 1987
- Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized studyAmerican Journal of Roentgenology, 1976